- Systems
- Consumables
- Point-of-Care Testing Devices
Latin America Hemostasis Diagnostics Market report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, test type, technology, end-user and region. This report studies Latin America Hemostasis diagnostics Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers, and service providers engaged. Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as stopping or slowing the blood flow from damaged blood vessel. During hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the prevalence of hemophilia in Latin America region (according to World Federation of Hemophilia Global Survey 2010, approximately 10,065 hemophilia cases were observed in Brazil), economic growth, and expansion of business by market players into Latin America region are anticipated to fuel the market. However, high cost of advanced hemostasis products, and regulatory bottlenecks for the test approvals are expected to hamper the growth of hemostasis diagnostics market.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
[urltag url='request-table-of-content']